PharmatrophiX Obtains $10,300,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e698b05-ff59-4ccd-a7d2-964032855b69
Date
11/23/2015
Company Name
PharmatrophiX
Mailing Address
2300 Wells Fargo Capitol Center Raleigh, NC 27601 USA
Company Description
PharmatrophiX is a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
Website
http://www.pharmatrophix.com
Transaction Type
Debt
Transaction Amount
$10,300,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed